LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 42

Search options

  1. Article ; Online: Management of Patients with Chronic Liver Disease in the Perioperative Period.

    Oliver, Joseph B / Merchant, Aziz M / Koneru, Baburao

    Journal of investigative surgery : the official journal of the Academy of Surgical Research

    2022  Volume 36, Issue 1, Page(s) 2156346

    MeSH term(s) Humans ; Perioperative Period ; Liver Diseases/surgery ; Perioperative Care
    Language English
    Publishing date 2022-12-14
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 639444-9
    ISSN 1521-0553 ; 0894-1939
    ISSN (online) 1521-0553
    ISSN 0894-1939
    DOI 10.1080/08941939.2022.2156346
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization.

    Oliver, Joseph B / Merchant, Aziz M / Koneru, Baburao

    Journal of investigative surgery : the official journal of the Academy of Surgical Research

    2019  Volume 34, Issue 6, Page(s) 617–626

    Abstract: Background: Multiple studies have shown high rates of postoperative morbidity and mortality in individuals with chronic liver disease (CLD). However, analyses from comparisons with individuals without CLD are not available. Such analyses might provide ... ...

    Abstract Background: Multiple studies have shown high rates of postoperative morbidity and mortality in individuals with chronic liver disease (CLD). However, analyses from comparisons with individuals without CLD are not available. Such analyses might provide opportunities to improve outcomes.
    Methods: Data from The National Surgical Quality Improvement Program (NSQIP) from 2008 to 2011 were analyzed comparing CLD patients undergoing non-liver surgery propensity matched to those without CLD. Patients with CLD were stratified by Model of End Stage Liver Disease (MELD) scores <15 and ≥15. Primary outcome was all cause mortality, and secondary outcomes were composite and individual morbidity, hospital length of stay, readmission, reoperation, and discharge destination. Odds ratios (OR) were calculated, and length of hospital stay was estimated using Poisson regression.
    Results: There were 6,209 patients with CLD (4,013 with low MELD, 2,196 with high MELD) matched to 18,627 patients without. Patients with CLD had 1.8- and 3.3-times higher odds of mortality (95% CI 1.6-2.1 for Low MELD (10.6%), 2.9-3.8 for high MELD (35.2%), and 1.8- and 2.2-times higher odds of any morbidity (1.6-1.9 and 1.9-2.4). Complications specific to CLD were increased based on MELD specifically coma (OR 1.6, 0.9-2.9 for Low MELD, 2.2, 1.5-3.2 for High MELD), renal failure (OR 1.4, 1.1-1.8 and 2.4, 2.0-2.9), and bleeding (OR 1.7, 1.5-1.9 and 2.0, 1.8-2.3). They also had a 20% and 80% longer length of stay, 2.2- and 3.4-times higher odds of being discharged somewhere other than home, 1.7- and 1.6-times higher odds of readmission, and 1.5- and 1.6-times higher odds of reoperation.
    Conclusion: Patients with CLD have significantly higher odds of mortality and morbidity, which is increased with a higher MELD. Interventions that decrease those morbidities are needed and have the potential to decrease mortality and resource utilization.
    MeSH term(s) End Stage Liver Disease/surgery ; Humans ; Length of Stay ; Liver Diseases/epidemiology ; Liver Diseases/surgery ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Reoperation ; Retrospective Studies ; Risk Factors
    Language English
    Publishing date 2019-10-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639444-9
    ISSN 1521-0553 ; 0894-1939
    ISSN (online) 1521-0553
    ISSN 0894-1939
    DOI 10.1080/08941939.2019.1676846
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Improved Outcomes Following Hepatocellular Carcinoma (HCC) Diagnosis in Patients Screened for HCC in a Large Academic Liver Center versus Patients Identified in the Community.

    Okoronkwo, Nneoma / Wang, Yucai / Pitchumoni, Capecomorin / Koneru, Baburao / Pyrsopoulos, Nikolaos

    Journal of clinical and translational hepatology

    2017  Volume 5, Issue 1, Page(s) 31–34

    Abstract: Background and Aims: ...

    Abstract Background and Aims:
    Language English
    Publishing date 2017-02-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3019822-7
    ISSN 2310-8819 ; 2225-0719
    ISSN (online) 2310-8819
    ISSN 2225-0719
    DOI 10.14218/JCTH.2016.00051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Resolving issues of consent and oversight: one step closer to terra firma in deceased organ donor research.

    Mora-Esteves, Cesar / Koneru, Baburao

    Critical care medicine

    2011  Volume 39, Issue 2, Page(s) 400–401

    MeSH term(s) Critical Illness/mortality ; Female ; Humans ; Informed Consent/ethics ; Informed Consent/legislation & jurisprudence ; Intensive Care Units ; Male ; Needs Assessment ; Organ Transplantation/standards ; Organ Transplantation/trends ; Presumed Consent/ethics ; Presumed Consent/legislation & jurisprudence ; Tissue Donors/ethics ; Tissue Donors/legislation & jurisprudence ; Tissue and Organ Procurement/ethics ; Tissue and Organ Procurement/legislation & jurisprudence ; Tissue and Organ Procurement/organization & administration ; United States
    Language English
    Publishing date 2011-02
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0b013e318206b0eb
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Ministering to the dead in critical care medicine: has its time come?

    Desai, Kunj K / Koneru, Baburao

    Critical care medicine

    2009  Volume 37, Issue 8, Page(s) 2480–2481

    MeSH term(s) Biomarkers/blood ; Hemodynamics ; Humans ; Hypovolemia/blood ; Hypovolemia/diagnosis ; Interleukin-6/blood ; Systemic Inflammatory Response Syndrome/blood ; Systemic Inflammatory Response Syndrome/prevention & control ; Tissue and Organ Harvesting
    Chemical Substances Biomarkers ; Interleukin-6
    Language English
    Publishing date 2009-08
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0b013e3181abf8ba
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues.

    Dikdan, George S / Mora-Esteves, Cesar / Koneru, Baburao

    Transplantation

    2012  Volume 94, Issue 5, Page(s) 425–441

    Abstract: Given the static number of deceased donors, improvements in donor management and organ preservation to increase the number and quality of organs transplanted per donor are more pressing. Because controlled trials provide the best evidence, we conducted a ...

    Abstract Given the static number of deceased donors, improvements in donor management and organ preservation to increase the number and quality of organs transplanted per donor are more pressing. Because controlled trials provide the best evidence, we conducted a review of English-language literature of trials in donor management and organ preservation to provide a compendium and to promote additional discussion and studies. Eighty-seven reports were retrieved: 13 on hemodynamic and fluid management, 7 on immunosuppressants, 12 on preconditioning, 34 on preservation fluids, and 21 on pulsatile perfusion. Sixteen studies are ongoing. Although hormonal therapy is used widely, additional studies are needed to determine the benefit of thyroid hormone and insulin replacement and to optimize steroid regimens. Dopamine's success in reducing kidney delayed graft function highlights the opportunity for additional preconditioning trials of remote ischemia, gases, opioids, and others. More rapid progress requires addressing unique barriers in consent and research approval, legal constraints precluding research in cardiac death donors, and streamlining collaboration of multiple stakeholders. With little interest from industry, federal funding needs to be increased. While the University of Wisconsin solution still reigns supreme, several promising preservative solutions and additives with not only biophysical but also pharmacological effects are on the cusp of phase 1 to 2 trials. After nearly three decades of uncertainty, the recent success of a European trial has reenergized the topic not only of machine preservation of the kidney but also of other organs evident by trials in progress. However, the costs of such technical innovations merit the burden of rigorous proof from controlled trials.
    MeSH term(s) Cytoprotection ; Donor Selection/methods ; Humans ; Organ Preservation/methods ; Organ Preservation Solutions/therapeutic use ; Organ Transplantation ; Perfusion ; Protective Agents/therapeutic use ; Pulsatile Flow ; Randomized Controlled Trials as Topic ; Tissue Donors/supply & distribution ; Tissue and Organ Procurement
    Chemical Substances Organ Preservation Solutions ; Protective Agents
    Language English
    Publishing date 2012-09-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/TP.0b013e3182547537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dr. Jekyll and Mr. Hyde saga of a cytokine: the devil in the details.

    Mora-Esteves, Cesar / Dikdan, George / Koneru, Baburao

    Critical care medicine

    2010  Volume 38, Issue 3, Page(s) 997–998

    MeSH term(s) Animals ; Capillary Permeability/immunology ; Lung/blood supply ; Lung Transplantation/physiology ; Postoperative Complications/immunology ; Primary Graft Dysfunction/physiopathology ; Pulmonary Edema/immunology ; Rats ; Reactive Oxygen Species/metabolism ; Reperfusion Injury/immunology ; Tumor Necrosis Factor-alpha/physiology
    Chemical Substances Reactive Oxygen Species ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2010-03
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0b013e3181ce2070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

    Oliver, Joseph Benton / Marcus, Andrea Fleisch / Paster, Mark / Nespral, Joseph / Bongu, Advaith / Dikdan, George / Brown, Lloyd / Neidlinger, Nikole / Koneru, Baburao

    Transplantation

    2017  Volume 101, Issue 4, Page(s) 821–825

    Abstract: Background: Prerecovery liver biopsy (PLB) allows histological evaluation of the organ before procurement. The opinions and what factors might influence PLB use within Organ Procurement Organizations (OPOs) are unknown.: Methods: A survey instrument ... ...

    Abstract Background: Prerecovery liver biopsy (PLB) allows histological evaluation of the organ before procurement. The opinions and what factors might influence PLB use within Organ Procurement Organizations (OPOs) are unknown.
    Methods: A survey instrument was distributed by the Association of OPOs to the clinical directors of all 58 OPOs. Descriptive statistics were calculated. Results were also stratified based on OPO characteristics.
    Results: Forty-nine (84.5%) of 58 OPOs responded to the survey; 40 (81.6%) of 49 currently perform PLB. This did not vary based on land mass, population, livers discarded, transplanted, donor age, or recipient MELD scores. Donor age, obesity, alcohol abuse, hepatitis serology, liver only donor, imaging results, and transplant center request were the most common indications for PLB in over 80% of OPOs. The median rate of performance is 5% to 10% of donors. Most use interventional radiologists to perform and the donor hospital pathologist/s to interpret PLB. Most OPOs believe PLBs are safe, reliable, useful, and performed often enough. Most say they did not believe they are easy to obtain. Beliefs were mixed regarding accuracy. The topics likely to influence PLB use were utility and accuracy of PLB, and availability of staff to perform PLB. OPOs that perform PLB more often were more likely to have favorable opinions of safety and pathologist availability, and more influenced by safety, reliability, availability, and a national consensus on the use of PLB.
    Conclusions: Considerable variability exists in the use of PLB. Additional information on the utility, accuracy, and safety of PLB are needed to optimize its use.
    MeSH term(s) Attitude of Health Personnel ; Biopsy/trends ; Cause of Death ; Donor Selection/trends ; Health Care Surveys ; Health Knowledge, Attitudes, Practice ; Humans ; Liver/pathology ; Liver Transplantation/trends ; Practice Patterns, Physicians'/trends ; Predictive Value of Tests ; Reproducibility of Results ; Risk Factors ; Tissue Donors ; United States
    Language English
    Publishing date 2017-01-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/TP.0000000000001632
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Hepatic steatosis and liver transplantation current clinical and experimental perspectives.

    Koneru, Baburao / Dikdan, George

    Transplantation

    2002  Volume 73, Issue 3, Page(s) 325–330

    MeSH term(s) Animals ; Disease Models, Animal ; Fatty Liver/complications ; Fatty Liver/epidemiology ; Fatty Liver/therapy ; Graft Survival ; Humans ; Liver Regeneration ; Liver Transplantation/adverse effects ; Prevalence ; Reperfusion Injury/etiology ; Tissue Donors
    Language English
    Publishing date 2002-02-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/00007890-200202150-00001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors.

    Lamba, Sangeeta / Nagurka, Roxanne / Desai, Kunj K / Chun, Shaun J / Holland, Bart / Koneru, Baburao

    Clinical transplantation

    2012  Volume 26, Issue 2, Page(s) 328–335

    Abstract: Adherence to immune suppressants and follow-up care regimen is important in achieving optimal long-term outcomes after organ transplantation. To identify patients most at risk for non-adherence, this cross-sectional, descriptive study explores the ... ...

    Abstract Adherence to immune suppressants and follow-up care regimen is important in achieving optimal long-term outcomes after organ transplantation. To identify patients most at risk for non-adherence, this cross-sectional, descriptive study explores the prevalence and correlates of non-adherence to immune-suppressant therapy among liver recipients. Anonymous questionnaires mailed consisted of the domains: (i) adherence barriers to immune suppressants, (ii) immune suppressants knowledge, (iii) demographics, (iv) social support, (v) medical co-morbidities, and (vi) healthcare locus of control and other beliefs. Overall response was 49% (281/572). Data analyzed for those transplanted within 10 yr of study reveal 50% (119/237) recipients or 9.2/100 person years reporting non-adherence. Non-adherence was reported highest in the 2-5 yr post-transplant phase (69/123, 56%). The highest immune-suppressant non-adherence rates were in recipients who are: divorced (26/34, 76%, p=0.0093), have a history of substance or alcohol use (42/69, 61%, p=0.0354), have mental health needs (50/84, 60%, p=0.0336), those who missed clinic appointments (25/30, 83%, p<0.0001), and did not maintain medication logs (71/122, 58%, p=0.0168). Respondents who were non-adherent with physician appointments were more than four and a half times as likely (OR 4.7, 95% CI 1.5-14.7, p=0.008) to be non-adherent with immune suppressants. In conclusion, half of our respondents report non-adherence to immune suppressants. Factors identified may assist clinicians to gauge patients' non-adherence risk and target resources.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Internal-External Control ; Liver Transplantation ; Male ; Medication Adherence ; Middle Aged ; Social Support ; Socioeconomic Factors ; Substance-Related Disorders ; Surveys and Questionnaires ; Young Adult
    Chemical Substances Immunosuppressive Agents
    Language English
    Publishing date 2012-03
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 639001-8
    ISSN 1399-0012 ; 0902-0063
    ISSN (online) 1399-0012
    ISSN 0902-0063
    DOI 10.1111/j.1399-0012.2011.01489.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top